Literature DB >> 19199361

Weight loss, body fat mass, and leptin in Parkinson's disease.

Birgitta Lorefält1, Göran Toss, Ann-Kathrine Granérus.   

Abstract

Weight loss is a common problem in Parkinson's disease (PD), but the causative mechanisms behind this weight loss are unclear. We compared 26 PD patients with sex and age matched healthy controls. Examinations were repeated at baseline, after one and after two years. Body fat mass was measured by Dual X-ray Absorptiometry (DXA). Seventy three per cent of the PD patients lost body weight. Loss of body fat mass constituted a considerable part of the loss of body weight. In the patients who lost weight, serum leptin levels were lower than in those who did not lose weight. The relationship between low body fat mass and low leptin levels seems to be relevant, at least for female PD patients. It is reasonable to believe that low leptin levels in these patients could be secondary to the decreased body fat mass. (c) 2009 Movement Disorder Society.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19199361     DOI: 10.1002/mds.22466

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  24 in total

1.  Repositioning leptin as a therapy for Alzheimer's disease.

Authors:  Jane M Johnston; Steven J Greco; Ashkan Hamzelou; J Wesson Ashford; Nikolaos Tezapsidis
Journal:  Therapy       Date:  2011-09

2.  Serum Leptin Levels and Cognition in Parkinson's Disease Patients.

Authors:  Gülay Kenangil; Betül Özdilek
Journal:  Noro Psikiyatr Ars       Date:  2016-09-01       Impact factor: 1.339

Review 3.  Metabolic dysfunction in Alzheimer's disease and related neurodegenerative disorders.

Authors:  Huan Cai; Wei-na Cong; Sunggoan Ji; Sarah Rothman; Stuart Maudsley; Bronwen Martin
Journal:  Curr Alzheimer Res       Date:  2012-01       Impact factor: 3.498

4.  Comparison of the mass and amount of intramuscular non-contractile tissue of the trunk and lower extremity muscles between patients with Parkinson's disease and community-dwelling older adults.

Authors:  Mitsuhiro Masaki; Maki Kasahara; Moeka Takeuchi; Kota Minakawa; Yukika Inagaki; Yukine Ogawa; Yoshino Sato; Minori Yokota; Seina Maruyama; Ryoko Usuki; Satomi Azuma; Shunsuke Obinata
Journal:  Neurol Sci       Date:  2022-01-18       Impact factor: 3.307

5.  Leptin promotes striatal dopamine release via cholinergic interneurons and regionally distinct signaling pathways.

Authors:  Maria Mancini; Jyoti C Patel; Alison H Affinati; Paul Witkovsky; Margaret E Rice
Journal:  J Neurosci       Date:  2022-07-20       Impact factor: 6.709

6.  Metabolic abnormalities and hypoleptinemia in α-synuclein A53T mutant mice.

Authors:  Sarah M Rothman; Kathleen J Griffioen; Kenneth W Fishbein; Richard G Spencer; Sokratis Makrogiannis; Wei-Na Cong; Bronwen Martin; Mark P Mattson
Journal:  Neurobiol Aging       Date:  2013-10-22       Impact factor: 4.673

Review 7.  Obesity and deep brain stimulation: an overview.

Authors:  Rahul Kumar; Constance V Simpson; Clifford A Froelich; Brandon C Baughman; Andrew J Gienapp; Karl A Sillay
Journal:  Ann Neurosci       Date:  2015-07

8.  Serum leptin concentrations in Turkish Parkinson's disease population.

Authors:  Betul Ozdilek; Gulay Kenangil
Journal:  Parkinsons Dis       Date:  2014-04-28

9.  The Relation of Circulating Levels of Leptin with Cognition in Patients with Alzheimer's Disease.

Authors:  Mustafa Ülker; Gülay Kenangil
Journal:  Noro Psikiyatr Ars       Date:  2018-06-05       Impact factor: 1.339

10.  Comprehensive urinary metabolomic profiling and identification of potential noninvasive marker for idiopathic Parkinson's disease.

Authors:  Hemi Luan; Liang-Feng Liu; Zhi Tang; Manwen Zhang; Ka-Kit Chua; Ju-Xian Song; Vincent C T Mok; Min Li; Zongwei Cai
Journal:  Sci Rep       Date:  2015-09-14       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.